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ABSTRACT
Trans-rectal prostate biopsy has become the gold standard for early diagnosis 
of prostate cancer in developing countries. Despite its low risk, there are 
some post-procedural complications. The complications are classified by 
using a modified Clavien-Dindo system. The study aimed to recognize 
complications of trans-rectal prostate biopsy procedure by using Clavien-
Dindo classification index. All patients undergoing trans-rectal prostate 
biopsy procedure in the Department of Urology, Dr. Soetomo General Hospital 
between January 2015-December 2019, were retrospectively analyzed in 
terms of post-procedural complaints, underlying comorbidities and ongoing 
additional examinations. The complaints were compiled into Clavien-Dindo 
classification. Univariate analysis of various predictors of post-procedural 
complications was also conducted. It was found 98 complication events from 
400 patients (24.5%). Most complications were 1st degree (dysuria, hematuria, 
urinary retention, fever, rectal pain and bleeding, erectile dysfunction, and 
constipation).  In univariate analysis, positive results of urinary culture 
correlated to the emergence of post-procedural complications. In conclusion, 
the incidence of post-trans-rectal prostate biopsy complication in Dr. Soetomo 
General Hospital reached 24.5%. From all of the risk factors, positive urinary 
culture is related to the post-biopsy complication. Most complications are in 
the 1st grade of Clavien index, suggesting that the procedure is relatively safe 
and has a low risk.
ABSTRAK
Biopsi prostat trans-rektal telah menjadi standar emas bagi diagnostik 
awal karsinoma prostat di negara berkembang. Meskipun relatif berisiko 
rendah, terdapat sejumlah komplikasi pasca-tindakan. Komplikasi tersebut 
diklasifikasi menggunakan sistem Clavien-Dindo yang dimodifikasi. 
Penelitian ini bertujuan untuk mengetahui komplikasi dari prosedur 
biopsi prostat trans-rektal dengan menggunakan indeks klasifikasi Clavien-
Dindo. Semua pasien yang menjalani prosedur biopsi prostat trans-rektal 
di Departemen Urologi, RSUD Dr. Soetomo, Surabya dari bulan Januari 
2015-Desember 2019, dianalisis secara retrospektif dalam hal keluhan pasca-
tindakan serta komorbid yang mendasari dan pemeriksaan penunjang 
yang telah dilalui. Keluhan tersebut dikompilasi dalam sistem klasifikasi 
Clavien-Dindo. Analisis univariat dari berbagai prediktor komplikasi pasca-
tindakan juga dilakukan. Ditemukan 98 kejadian komplikasi yang muncul 
dari antara 400 pasien (24.5%). Sebagian besar komplikasi berada di derajat 
I. Dalam analisis univariat, hasil kultur urine yang positif berhubungan 
dengan timbulnya komplikasi pasca-tindakan. Dapat disimpulkan, insidensi 
komplikasi pasca-biopsi prostat trans-rektal di RSUD Dr. Soetomo mencapai 
24.5%. Dari semua faktor risiko, kultur urine positif berhubungan dengan 
komplikasi pasca-biopsi. Sebagian besar komplikasi termasuk dalam indeks 
Clavien derajat I, menunjukkan bahwa prosedur ini relatif aman dan berisiko 
rendah. 
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INTRODUCTION
Trans-rectal ultrasound (TRUS) of 
the prostate is a sonographic imaging 
procedure mostly carry out by urologists.1 
This procedure is often followed by 
prostate biopsy, which has become the 
standard procedure since 1989.2 It is 
mostly conducted due to specific clinical 
indication, either increasing prostate 
specific antigen (PSA) level or abnormal 
finding on rectal toucher.1 Sextant biopsy 
hasn’t been considered adequate. At least 
8 systematic biopsies are recommended 
in prostates measuring ± 30 cc. In 
larger prostates, 10-12 core biopsies are 
recommended.3
Although being considered 
relatively safe out-patient procedure, the 
incidence of post-biopsy complications 
is attached to the procedure itself.4 
Potential complications on trans-rectal 
prostate biopsy include hematospermia 
(6.5-74.4%), hematuria (<14.5%), and 
rectal bleeding (2.2%).5 There have been 
historical concerns about performing 
trans-rectal prostate biopsy for patients 
on anticoagulation/antiplatelet therapy 
due to its bleeding complications. 
However, Raheem et al.6 reported that 
there was no statistical difference in 
rectal bleeding event between treatment 
(with anti-coagulation/anti-platelet 
therapy) and control groups (without 
anti-coagulation/anti-platelet therapy), 
suggesting the safety of continuation of 
anti-coagulant/anti-platelet treatment 
before trans-rectal prostate biopsy. 
Other post-biopsy complications are 
infection (6.6%), severe rectal bleeding 
(1%), urinary obstruction (<4.6%), acute 
bacterial prostatitis, and urosepsis 
(0.3%).5 
Due to the lack of a uniform 
reporting system, there is a considerable 
inconsistency from the available 
data. Terms like major and minor 
complications have been used, but not 
standardized, which causes difficulties 
in comparison of complications. The 
absence of consensus in grouping and 
inhomogeneity within reporting system 
has added the obstacles.7 To resolve the 
problems, Clavien et al.8 proposed a 
classification of surgical complications 
based on experience and analysis 
from 650 patients who underwent 
cholecystectomy.8 In 2004, Dindo et al.9 
improved the classification system, and 
the so-called Clavien-Dindo classification 
system has been standardized for the 
registration of surgical complications 
since then.10  This system is composed 
of 5 grades and the suffix “d” (for 
“disability”) is used to denote any 
post-operative impairment,11 as seen 
in TABLE 1. The stratification of this 
system depends on the severity of the 
complication and the invasiveness of 
the required intervention. Although not 
being designed for urologic surgery, the 
application of Clavien-Dindo system has 
been validated, and it has been proven to 
be simple, reproducible, and applicable 
in urologic field.1
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TABLE 1. Clavien-Dindo classification of complications12
Grade Definitions
I Any deviation from the normal postoperative course without the need for 
pharmacologic treatment or surgical, endoscopic, or radiologic intervention.
Allowed therapeutic regimens include anti-emetics, antipyretics, analgesics, 
diuretics, and so on. This grade also includes wound infections opened at the 
bedside.
II Requiring pharmacologic treatment with medications/pharmacologic 
interventions other than those allowed for grade I complications.
Blood transfusions and total parenteral nutrition are also included.
III Requiring surgical, endoscopic, or radiologic intervention.
IIIa Intervention not under general anesthesia.
IIIb Intervention under general anesthesia.
IV Life-threatening complications (including central nervous system [CNS] 
complications) requiring intermediate care/intensive care unit management.
IVa Single organ dysfunction (including dialysis).
IVb Multi-organ dysfunction.
V Death of a patient.
Brain hemorrhage, ischemic stroke, subarachnoid bleeding. This excludes transient 
ischemic attacks (TIAs).
The purpose of this study is to 
recognize complications of trans-rectal 
prostate biopsy procedure by using 
Clavien-Dindo classification index. A 
retrospective study was conducted by 
means of medical records of all patients 
who underwent trans-rectal prostate 
biopsy in our institution between 
January 2015-December 2019. Before 
collecting data from medical records, 
we ensured if all medical records have 
attached informed consent to extract 
data for scientific purposes. By reviewing 
all medical records, we sought to identify 
patients’ demographic and prostate 




The study was conducted 
retrospectively with analytic descriptive 
design. The data of 400 patients diagnosed 
with benign prostate hyperplasia 
or suspicious prostate cancer who 
underwent trans-rectal prostate biopsy 
between January 2015 to December 2019 
in the Urogenital Invasive Unit of Dr. 
Soetomo General Hospital, Surabaya, 
Indonesia were analyzed. The protocol 
of study has received approval from the 
Ethical Committee for Medical Research 
in Dr. Soetomo General Hospital (number 
of certificate 1856/109/XII/2019).
Protocol of study
We ensured if all medical records 
have attached informed consent to 
extract data for scientific purposes. 
The data collection was conducted by 
obtaining all patients’ register numbers, 
then tracing in register books and 
printed or electronic medical records. 
We therefore recorded the patients’ 
identities, such as age, comorbidity, 
PSA value, average prostate volume, 
urinary culture, pathological results, 
post-procedural symptoms. We also 
looked for pathological results from 
the Anatomical Pathology Department, 
urinary culture from the Clinical 
267
J Med Sci, Volume 53, Number 3, 2021 July: 264-273
Microbiology Department, and PSA value 
from Clinical Pathology Department. The 
inclusion criteria were all patients who 
underwent trans-rectal prostate biopsy 
in our institution between 2015 to 2019, 
regardless of pre-biopsy diagnosis and PA 
result, and the biopsy had to be done in, 
at least, 10 sites in the prostate. Patients 
were excluded from this research if 
the procedure of prostate biopsy was 
performed from other approaches, for 
example trans-perineal or trans-urethral 
prostate biopsy, and less than 10 sites in 
the prostate (eg. sextant-core biopsy).
Statistical analysis
The data were descriptively 
analyzed. The complications were 
graded according to the Clavien-Dindo 
classification system. The system is 
highly recommended due to its simplicity 
and comprehensive nature, after which 
the data were presented in graphics. 
The factors which led to post-procedural 
complications were analyzed by means 
of univariate analysis and chi-square 
test by utilizing SPSS 18.0 software.
RESULTS
Descriptive data of trans-rectal 
prostate biopsy patients is presented in 
TABLE 2. Overall, there are 312 patients 
(78%) who underwent 10-core biopsy 
and the remaining 88 (22%) underwent 
11 and 12-core biopsy due to hypoechoic 
area in the ultrasonography screen.
TABLE 2. Descriptive data on patients who underwent 
trans-rectal prostate biopsy.
Variable Total patients
Age (mean ± SD year) 65.18 ± 7.78
Mean PSA value (ng/mL) 119.69 ± 492.29
Mean prostate volume (mL) 50.02 ± 26.81
Mean PSA density (ng/mL) 3.04 ± 14.17
Urinary culture [n (%)]
•	Positive 197 (49.25)
•	Negative 203 (50.75)
Total core biopsy [n (%)]
•	10 core 312 (78.00)
•	11 core 84 (21.00)
•	12 core 4 (1.00)
PA results [n (%)]
•	BPH/no malignancy 272 (68.00)
•	PIN 4 (1.00)
•	Prostate adenocarcinoma 105 (26.25)
•	TCC 5 (1.25)
•	SCC 1 (0.25)
•	Prostatitis (acute and chronic) 10 (2.50)
•	Tuberculous prostatitis 3 (0.75)
PSA: prostate specific antigen; SD: standard of 
deviation; PIN: prostate intra-epithelial neoplasia; 
TCC: transitional cell carcinoma; SCC: squamous cell 
carcinoma
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TABLE 3 shows post-procedural 
complications classified according to 
modified Clavien-Dindo classification. 
Overall, there are 98 complication 
events of 400 patients (24.5%), divided 
in 5 grades (I, II, IIIa, IIIb, and IV). It 
could be seen from TABLE 3 that most 
complications are in the 1st grade (82 
complications (20.5%)).
TABLE 3. Post-operative grade of complication 
according to modified Clavien-Dindo 
classification system
Grade of complications Total complications
Grade I [n (%)] 82 (20.50)
•	Fever 10 (2.50)
•	Rectal pain 9 (2.25)
•	Dysuria 26 (6.50)
•	Rectal bleeding 3 (0.75)
•	Constipation 1 (0.25)
•	Urinary retention 11 (2.75)
•	ED 2 (0.50)
•	Hematuria 20 (5.00)
Grade II [n (%)] 13 (3.25)
•	UTI 10 (2.50)
•	Anemia 2 (0.50
Grade IIIa [n (%)] 1 (0.25)
Clot retention without surgical 
intervention (manual irrigation)
Grade IIIb [n (%)] 1 (0.25)
Clot retention with surgical 
intervention (cystoscopy and clot 
evacuation)
Grade IV [n (%)] 2 (0.50)
Sepsis
ED: erectile dysfunction; UTI: urinary tract infection
TABLE 4 presents univariate 
analysis from various predictors of 
complication after trans-rectal prostate 
biopsy. Only positive pre-biopsy 
urinary culture significantly correlated 
with the increased post-biopsy rate of 
complications (p=0.042). Whereas, the 
other predictors were not considered 
statistically significant (p >0.05).
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Diabetes mellitus 49 9 40 0.795
Hypertension 193 37 158 0.433
Other cardiovascular diseases 37 9 28 0.463
Cancer other than prostate/urology 13 6 7 0.310
Cerebrovascular accident 19 3 16 0.301
Other neurological disorders 3 1 2 0.553
Respiratory tract disorders 9 1 8 0.510
Pulmonary infections 16 4 12 0.590
Other infections 11 4 7 0.160
Melena 1 0 1 0.619
Core >10 88 16 72 0.676
Pre-biopsy positive urinary culture 197 47 150 0.042*
DISCUSSION
Trans-rectal ultrasound biopsy 
is a useful modality for all urologists 
to diagnose prostate cancer. The 
complications of trans-rectal prostate 
biopsy are reported up to 50% cases and 
range from minor complications which 
only need reassurance for the patients 
like hematuria, hematospermia, rectal 
bleeding, acute urinary retention, until 
worse complications which requires 
medical or surgical interventions, such 
as anemia, syncope, febrile UTI, and 
septic shock.4,13 It is showed from this 
study that the overall complication rates 
according to Clavien-Dindo classification 
system reached 24.5%.
Post-biopsy complications include 
hematuria, infection, lower urinary 
tract symptoms (LUTS), and pain, and 
its hospitalization rates are required in 
a minority of patients.14 As reported in 
English literature, the complication rate 
ranges between 3-11% and severe sepsis 
rate is estimated <1%.15 In this study, only 
fever and UTI complication rates are 2.5% 
and 2.5% from overall cases, lower than 
that report. The rates have been graded 
according to the Clavien index. Fever can 
accompany other complications such as 
UTI and sepsis.
From the entire patients who 
underwent trans-rectal prostate biopsy, 
there were 2 (0.5%) who suffered 
erectile dysfunction. The number is far 
lower than reported by Yanaral et al.16 
who recorded ED event ranging from 
28.8% for mild ED until 5% for severe 
ED. The exact etiology of post-biopsy 
ED is unknown, possibly because of 
inflammation within immediate post-
procedural time, and little damage in 
neuro-vascular bundles due to the biopsy 
needle. There are some speculations that 
the ED’s components may be related to 
the psychological impact on cancer or 
accepting prostate cancer diagnosis.17 
Despite of that, ED complaint won’t be 
durable, as studied by Wibisono et al.18 
who found out the improved erection 
hardness score (EHS) and international 
index of erectile function-5 (IIEF-5) 
scores in the first week after prostate 
biopsy.18
In 2013, a systematic review 
reported that bleeding symptoms such 
as hematuria and rectal bleeding ranged 
from 5-19% and 1.3-45%, respectively. 
In this study, hematuria was found in 
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5% patients, and rectal bleeding was 
0.75%. Minor bleeding symptom could 
be neglected; thus it was not reported. 
Most bleeding events were only mild and 
transient.19
Post-biopsy urinary retention urine 
was found in 2.75% patients, higher 
than reported in literature (0.2-1.7%). 
There are many factors influencing the 
incidence of post-procedural urinary 
retention, such as large prostate size, 
transitional zone to total prostate volume 
ratio, and higher IPSS score. It seems 
that there is no correlation between 
the number of biopsy cores taken or 
the number of repeat serial biopsies 
performed and LUTS.17
Overall, the 3rd-grade complication 
(clot retention) occurred in one patient 
(0.25%), which resulted in clot evacuation 
procedure with regional anesthesia. 
Besides, there was one patient (0.25%) 
who suffered clot retention, but could be 
treated just by catheter irrigation. Efesoy 
et al.20 reported that 0.25-0.7% hematuria 
event could cause either clot retention or 
anemia which required transfusion.20
The 4th-grade complication consists 
of dysfunction of single or multi-organs 
which requires intensive care. It was 
visible in 0.5% cases, in accordance with 
a report in an English literature which 
mentioned that severe sepsis event was 
less than 1%. The proposed mechanism 
related to infection is the possibility 
of bacteria entering the bladder and 
blood flow from rectum, where the 
most common organism responsible 
for the infection event is Escherichia 
coli. The factors which could predict 
the infection event were: underlying 
medical comorbidity, especially diabetes 
mellitus, urethral catheterization, and 
previous hospitalization.15
In this study, univariate analysis 
of certain factors seemingly resulting 
in complication of surgical procedure 
was also performed. It was found that 
the positive pre-procedural urinary 
culture might have a relation with the 
significantly increasing complication 
incidence. The study of Bruyère et 
al.21 suggested that routine pre-biopsy 
urinary culture had no benefit after the 
administration of antibiotic prophylaxis 
and enema. Instead, they suggested to 
take pre-procedural urinary culture in 
patients who had previous UTI history.
We acknowledge several 
limitations, which could be attributed 
to the retrospective nature of our study. 
Many participants may forget the 
complications they have experienced, 
causing the complications themselves 
may not be written in medical records. 
The result of our study may not 
exactly mirror the study from a larger 
heterogeneous because it is conducted 
in a single institution (which makes 
our study population smaller). It is also 
partly caused by the short period of this 
retrospective study (5 years). Because of 
that, our study isn’t powered adequately 
to query all potential predictive variables 
of interest.
The modified Clavien system 
categorizes complication in standardized 
manner. The system could also be utilized 
to assess internal quality and evaluate 
learning curve for certain procedures.22 
However, the Clavien system indeed 
has some shortcomings. There may 
be a variation of a complication grade 
between many institutions. A procedure 
routinely performed without anesthesia 
in one institution (grade IIIA) may be 
carried out under general anesthesia 
(grade IIIB) in other institutions. The 
subdivision of group III is only based 
on anesthetic type, not on its surgical 
procedure. Indication for intensive 
care also differs across hospitals. The 
rates of intensive care admission are 
determined by various factors, such 
as economical consideration of the 
patient, hospital’s policy, physicians’ 
preference, and insurance policy. 
Intensive care may also be indicated 
due to anesthetic complications, not 
merely surgical one. Besides, there is no 
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consensus whether some events must be 
considered as a complication or routine 
sequel of a surgery.8 For example, 
acute urinary retention due to trans-
rectal prostate biopsy is considered as 
a minor complication in a study, but 
major one in another study.23,24 Elkoushy 
et al.25 reported that inter-urologist 
understanding level in application of 
revised Clavien-Dindo classification 
could be said good.
CONCLUSION
In conclusion, the incidence of 
overall complications of post-trans-
rectal prostate biopsy in Dr. Soetomo 
General Hospital, Surabaya reaches 
24.5%. From all of the risk factors, 
pre-biopsy positive urinary culture is 
related to the post-biopsy complication. 
Most complications are in the 1st grade 
of Clavien index, suggesting that the 
procedure is relatively safe and has a 
low risk. The Clavien-Dindo system is 
simple and useful in classifying post-
surgical/procedure complication despite 
many limitations. Further investigation 
is needed to minimize the recording bias 
with a prospective approach.
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